Table 3.
Mean Symptom Dimension Severity Ratings
| Baseline Symptom Ratings | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Antipsychotics |
SSRIs* |
Other Antidepressants (OD) |
|||||||
| Symptom Dimension | No Antipsychotic(n = 143) Mean (SD) | Follow-up only (n = 31 Mean (SD)) | Baseline & Follow-up (n = 13) Mean (SD) | No SSRI (n = 116) Mean (SD) | Follow-up only (n = 20) Mean (SD) | Baseline & Follow-up (n = 40) Mean (SD) | No OD (n = 151) Mean (SD) | Follow-up only (n = 12) Mean (SD) | Baseline & Follow up (n = 24) Mean (SD) |
| Positive | a 11.91 (4.04) | 12.81 (3.51) | a 14.42 (5.00) | 12.74 (4.34) | 12.30 (4.65) | 11.15 (2.90) | 12.30 (4.28) | 10.94 (3.65) | 11.81 (2.94) |
| Negative | 10.75 (7.11) | 14.83 (6.14) | 14.45 (8.26) | 11.65 (7.57) | 12.15 (6.45) | 11.47 (6.84) | 11.73 (7.26) | 16.07 (6.68) | 11.08 (7.51) |
| Disorganized | ab 5.63 (3.54) | a 7.90 (3.81) | b 9.28 (3.96) | 6.49 (3.74) | 6.42 (4.13) | 5.84 (3.84) | 6.23 (3.72) | 7.21 (4.64) | 5.44 (3.78) |
| General | 7.47 (4.00) | 10.74 (4.13) | 8.72 (4.75) | 7.32 (4.16) | 10.15 (4.25) | 9.05 (4.23) | 7.65 (4.26) | 9.59 (3.48) | 9.42 (4.06) |
| Follow-up Symptom Ratings (Corrected for covariates) | |||||||||
| Antipsychotics |
SSRIs |
Other Antidepressants |
|||||||
| Symptom Dimension | No Antipsychotic(n = 143) Mean (SD) | Follow-up only(n = 31) Mean (SD) | Baseline & Follow-up (n = 13) Mean (SD) | No SSRI (n = 116) Mean (SD) | Follow-up only (n = 20) Mean (SD) | Baseline & Follow-up (n = 40) Mean (SD) | No OD (n = 151) Mean (SD) | Follow-up only (n = 12) Mean (SD) | Baseline & Follow-up (n = 24) Mean (SD) |
| Positive | 7.20 (5.17) | 6.33 4.69) | 6.75 (5.51) | 7.31 (5.36) | 6.65 (5.05) | 6.58 (4.75) | 7.20 (5.20) | a 9.12 (5.93) | a 5.60 (3.32) |
| Negative | 7.82 (7.67) | 9.55 (7.38) | 11.39 (7.38) | 8.94 (7.75) | 6.53 (6.64) | 7.66 (7.08) | 8.34 (7.46) | 13.77 (9.94) | 6.38 (6.05) |
| Disorganized | 3.99 (3.71) | 4.64 (2.95) | 5.03 (4.20) | 4.19 (3.79) | 4.39 (3.31) | 4.17 (3.27) | 4.19 (3.71) | 5.95 (4.09) | 3.09 (2.57) |
| General | 4.80 (4.50) | 6.85 (4.32) | 4.01 (4.96) | 4.85 (4.42) | 6.60 (3.71) | 5.48 (5.31) | 4.89 (4.44) | 8.13 (6.18) | 5.24 (3.99) |
a,b
denotes pairs of means significantly different at p<.05
*
11 subjects on SSRIs at baseline but not follow-up are not included in this table